Your browser doesn't support javascript.
loading
MICA/B-targeted antibody promotes NK cell-driven tumor immunity in patients with intrahepatic cholangiocarcinoma.
Oliviero, Barbara; Varchetta, Stefania; Mele, Dalila; Pessino, Greta; Maiello, Roberta; Falleni, Monica; Tosi, Delfina; Donadon, Matteo; Soldani, Cristiana; Franceschini, Barbara; Torzilli, Guido; Piccolo, Gaetano; Barabino, Matteo; Opocher, Enrico; Maestri, Marcello; Bernuzzi, Stefano; Wucherpfennig, Kai W; Mondelli, Mario U; Mantovani, Stefania.
Afiliación
  • Oliviero B; Division of Clinical Immunology - Infectious Diseases, Department of Medicine, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Varchetta S; Division of Clinical Immunology - Infectious Diseases, Department of Medicine, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Mele D; Division of Clinical Immunology - Infectious Diseases, Department of Medicine, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Pessino G; Division of Clinical Immunology - Infectious Diseases, Department of Medicine, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Maiello R; Department of Molecular Medicine, University of Pavia, Pavia, Italy.
  • Falleni M; Department of Pathology, Department of Health Sciences, ASST Santi Paolo e Carlo, State University of Milan, Milan, Italy.
  • Tosi D; Department of Pathology, Department of Health Sciences, ASST Santi Paolo e Carlo, State University of Milan, Milan, Italy.
  • Donadon M; Department of Hepatobiliary and General Surgery, Humanitas Clinical and Research Center, Humanitas University, Rozzano, Italy.
  • Soldani C; Department of Hepatobiliary and General Surgery, Humanitas Clinical and Research Center, Humanitas University, Rozzano, Italy.
  • Franceschini B; Department of Hepatobiliary and General Surgery, Humanitas Clinical and Research Center, Humanitas University, Rozzano, Italy.
  • Torzilli G; Department of Hepatobiliary and General Surgery, Humanitas Clinical and Research Center, Humanitas University, Rozzano, Italy.
  • Piccolo G; Division of Gastrointestinal Surgery, ASST Santi Paolo e Carlo, and State University of Milan, Milan, Italy.
  • Barabino M; Division of Gastrointestinal Surgery, ASST Santi Paolo e Carlo, and State University of Milan, Milan, Italy.
  • Opocher E; Division of Gastrointestinal Surgery, ASST Santi Paolo e Carlo, and State University of Milan, Milan, Italy.
  • Maestri M; Division of General Surgery 1, Department of Surgery, Fondazione Irccs Policlinico San Matteo, Pavia, Italy.
  • Bernuzzi S; Immunohematology and Transfusion Service, Department of Diagnostic Medicine, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Wucherpfennig KW; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Mondelli MU; Division of Clinical Immunology - Infectious Diseases, Department of Medicine, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Mantovani S; Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.
Oncoimmunology ; 11(1): 2035919, 2022.
Article en En | MEDLINE | ID: mdl-35223192
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de los Conductos Biliares / Colangiocarcinoma Límite: Humans Idioma: En Revista: Oncoimmunology Año: 2022 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de los Conductos Biliares / Colangiocarcinoma Límite: Humans Idioma: En Revista: Oncoimmunology Año: 2022 Tipo del documento: Article País de afiliación: Italia